ASUi002-A

Registration Summary:

A P E C

384-iPSC

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	ASUi002-A
Cite as:	ASUi002-A (RRID:CVCL_QY81)
Alternative name(s)	384-iPSC
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	21st April 2017
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Arizona State University (ASU)
External Databases
Cellosaurus	CVCL_QY81
Wikidata	Q54750801
General Information
Publications	Brookhouser N et al. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. Stem cell research. 2017 Oct;24:160-163. Majolo F et al. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells. Journal of biomedical science. 2019 Feb 6;26(1):15. Raman S et al. Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk. Neurobiology of disease. 2020 May;138:104788. Zhao J et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids. Nature communications. 2020 Nov 2;11(1):5540. Nilsri N et al. Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model. Scientific reports. 2021 Mar 4;11(1):5255. Xu W et al. Folate as a potential treatment for lethal ventricular arrhythmias in TANGO2-deficiency disorder. JCI insight. 2024 Jun 10;9(11). İş Özkan et al. Gliovascular transcriptional perturbations in Alzheimer’s disease reveal molecular mechanisms of blood brain barrier dysfunction. Nature Communications. 2024-06-20.

hIPSC Derivation

General